Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study.

Chieh-Li YenChao-Yi WuLai-Chu SeeYi-Jung LiMin-Hua TsengWei-Sheng PengJia-Rou LiuYung-Chang ChenTzung-Hai YenYa-Chung TianChih-Wei YangGerard F AndersonHuang-Yu Yang

Published in: Diabetes care (2020)

Keyphrases

chronic kidney disease
end stage renal disease
cardiovascular events
quality improvement
risk factors
type diabetes